94681 ⎘
Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems; Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2 Aryl or substituted aryl radicals
Anion-exchange displacement chromatography process and anionic organic compounds for use as displacer compounds in anion-exchange displacement chromatography process
#302-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-phenyl-1-piperazinealkylamide derivatives, and therapeutic use thereof as 5-HTreceptor ligands
#303Composition and synthesis of new reagents for inhibition of HIV replication
#304Methods for treating transthyretin amyloid diseases
#305Novel compounds for the prophylaxis and treatment of inflammatory bowel diseases
#306Sirtuin modulating compounds
#307Sirtuin modulating compounds
#308NON-NUCLEOSIDE ANTI-HEPACIVIRUS AGENTS AND USES THEREOF
#309Substituted heterocyclic compounds
#310Substituted phenylacetic acids
#311Substituted Heteroaryl- and Phenylsulfamoyl Compounds
#312Substituted Heteroaryl- and Phenylsulfamoyl Compounds
#313Fused heterocyclic derivatives as PPAR modulators
#314Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators
#315Crystal forms of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol
#316Fused heterocyclic derivatives as PPAR modulators
#317Process for the purification of substituted benzoxazole compounds
#318Process for the preparation of substituted benzoxazole compounds
#319Ligands of adenine nucleotide translocase (ant) and compositions and methods related thereto
#320N- (3-amino-2-hydroxy-propyl) substituted alkylamide compounds
#321Therapeutic benzothiazole compounds
#322ER-B-SELECTIVE LIGANDS
#323Geminally di-substituted NSAID derivatives as Aβ42 lowering agents
#324Modulators of PPAR and methods of their preparation
#325Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
#326Quinazolinone compounds as calcilytics
#327Prodrug substituted benzoxazoles as estrogenic agents
#328Benzothiazole-and benzoxazole-4, 7-dione derivatives and their use as dcd25 phosphatase inhibitors
#329N-cyclic sulfonamido inhibitors of gamma secretase
#330Substituted aryl thioureas and related compounds; inhibitors of viral replication
#331Ligands of adenine nucleotide translocase (ANT) and compositions and methods related thereto
#332Substituted heteroaryl- and phenylsulfamoyl compounds
#333Naphthyl benzoxazoles and benzisoxazoles as estrogenic agents
#334Benzoxazole and benzodiazole UV-A sunscreens
#335Polymerizable, luminescent compounds and mixtures, luminescent polymer materials and their use
#336Substituted benzoxazoles as estrogenic agents
#337Substituted heteroaryl- and phenylsulfamoyl compounds
#338Anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production
#339Bicyclic derivative, its production and use
#340Process for producing biaryl compound
#341Substituted thiazolopyrimidines as xanthine oxidase inhibitors
#342Mediators of hedgehog signaling pathways, compositions and uses related thereto
#343Substituted benzoxazoles as estrogenic agents
#344Metabotropic glutamate receptor-5 modulators
#345Compositions and methods for the treatment of disease associated with Trp-p8 expression
#346UK-1 analogues: methods of preparation and use
#347N′-(1-naphthoyloxy)-2-(benzo[d]oxazol-2-yl)acetimidamide as an antimicrobial compound
#3482-(benzo[d]oxazol-2-yl)-N′-(4-(dimethylamino)benzoyloxy)acetimidamide as an antimicrobial compound
#3492-(benzo[d]oxazol-2-yl)-N′-(3,5-dichlorobenzoyloxy)acetimidamide as an antimicrobial compound
#350Polymorphic compounds and uses thereof